Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Insulin Pumps Articles

Mike Fisher, Competitive Snowboarder
#Six and Diabetes: Jay Cutler On Numbers
Crystal Bowersox: Striving to Live Without Limitations
Traveling With Diabetes
Children with Diabetes, You Are My True Inspiration
Incorporating Exercise Into a Busy Life
Diabetes Heroes Come In All Ages
Stylish Diabetes Supply Cases From Myabetic.com
Women and Diabetes: A New Book with Fresh Insight
Animas Receives Warning Letter From the FDA
Diabetes Health Reference Charts
Mail Order Reference Guide (PDF)
Insulin Pen Needles Reference Guide (PDF)
Insulin Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Insulin Pumps Reference Guide (PDF)
Infusion Sets Reference Guide (PDF)
Syringes Reference Guide (PDF)
Mail Order Reference Guide (PDF)
See All Charts…
Insulin Pumps Archives
Browse the Insulin Pumps Archives
Subscribe to the Products RSS Feed
Print | Email | Share | Comments (0)

Lipoatrophy Associated with Humalog Use in Insulin-Pump Therapy

Apr 1, 2001

If you use lispro (Humalog) insulin in your pump and are seeing dents in your skin at your infusion sites, a switch in insulin can stop the problem.

The situation, called lipoatrophy, happens when the fatty tissue under the skin disappears. Lipoatrophy, more common in the past, was believed to have been caused by reactions to insulins that are not as pure as today's human-origin compounds. However, at least three recent cases of lipoatrophy involving the use of Humalog in a pump has led doctors from the Yale University and West Virginia University schools of medicine to caution others to be on the lookout for the problem.

The doctors, writing in the "Letters" section of the January 2001 issue of Diabetes Care, observed two incidents of lipoatrophy and received correspondence from a colleague who observed one case.

Switching to human-based buffered Regular insulin in the form of Velosulin alleviated the problems with lipoatrophy.

Doctors say evidence points to Humalog—not the delivery system—as being the primary factor in causing lipoatrophy.

Categories: Complications & Care, Diabetes, Diabetes, Insulin, Insulin Pumps, Type 1 Issues

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Apr 1, 2001

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.